Regional News Archives - Page 77 of 190 - Journal for Clinical Studies

Current Edition

Regional News

AbbVie’s Rinvoq notches Crohn’s disease win amid classwide JAK safety concerns

AbbVie's blockbuster hopeful Rinvoq notched a win in a tricky-to-treat group of Crohn's disease patients, potentially adding another arrow to the company's post-Humir...

8 December 2021 Regional News AbbVie | Crohn's disease

Continue Reading →

Regional News

Merck’s Hilleman Laboratories tees up $58M investment at new Singapore vaccine hub

Singapore has attracted a slate of vaccine heavyweights in recent years. Now, a Merck joint venture is getting in on the action, following in the footsteps of compani...

8 December 2021 Regional News biologics | coronavirus

Continue Reading →

Regional News

GlaxoSmithKline and Vir’s sotrovimab stands up to omicron despite other COVID antibodies falling short

Amid reports that COVID-19 antibody treatments from Regeneron and Eli Lilly lose their effectiveness against the omicron variant, GlaxoSmithKline and Vir Biotechnolog...

8 December 2021 Regional News antibodies | Celltrion

Continue Reading →

Regional News

Former pharma CEO plundered millions from his own company, DOJ says

What not to do with millions of dollars of a pharma company's cash? Don't allegedly cover personal credit card bills and pay for tuition for your child's private scho...

8 December 2021 Regional News criminal case | Department of Justice

Continue Reading →

Regional News

Alvotech, battling AbbVie over its Humira biosim, raises $450M and tees up Nasdaq debut

Alvotech, the biosim specialist locked in a legal battle over AbbVie's sales Goliath Humira, is revving up for its debut on the Nasdaq. The Icelandic company is join...

8 December 2021 Regional News AbbVie | Alvotech

Continue Reading →

Regional News

Watch out, Pfizer and Alnylam. AstraZeneca wades deeper into rare diseases with Ionis tie-up

Just months after wrapping up the Alexion acquisition, AstraZeneca is beefing up its newly established rare disease portfolio with a collaboration with Ionis Pharmace...

8 December 2021 Regional News Alnylam Pharmaceuticals | AstraZeneca

Continue Reading →

Regional News

Novo Nordisk, Sanofi and Eli Lilly cut insulin prices and lose share in China’s latest cost squeeze

On the centennial of the discovery of insulin, China decided a round of price cuts on the diabetes therapy is due. As a result, foreign companies Novo Nordisk, Sanofi...

1 December 2021 Regional News china | drug prices

Continue Reading →

Regional News

Pfizer boosts Paxlovid manufacturing capacity as Merck’s rival COVID pill hits surprise efficacy setback

The efficacy data for Pfizer’s oral COVID-19 drug now look so appealing that the Big Pharma company is boosting manufacturing capacity even before an expected emergen...

1 December 2021 Regional News Albert Bourla | antivirals

Continue Reading →

Regional News

Amgen asks Supreme Court to take up its high-profile PCSK9 patent case against Sanofi and Regeneron

After Amgen earlier this year suffered a third consecutive loss in its high-profile PCSK9 patent feud with Sanofi and Regeneron, the company faced two choices: appeal...

1 December 2021 Regional News Amgen | lawsuit

Continue Reading →

Regional News

Moderna, Regeneron warn about the effectiveness of COVID-19 drugs, vaccines against the omicron variant

As the world assesses the threat posed by the COVID-19 omicron variant, two top companies producing pandemic drugs and vaccines have warned that their current offerin...

1 December 2021 Regional News BioNTech | COVID-19

Continue Reading →